Lyme Disease Testing Industry Overview 2025: Growth Projections and Market Trends

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Lyme Disease Testing Market?

The lyme disease testing market has experienced significant expansion in recent years. Its valuation is expected to climb from $9.77 billion in 2024 to $10.68 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.3%. The historic growth can be linked to an elevated demand for prompt disease identification, the increasing accessibility of sophisticated diagnostic technologies, a surge in tick populations attributed to climate change, increased government expenditure for controlling vector-borne illnesses, and the advancement of healthcare infrastructure in rural and affected areas.

The lyme disease testing market is projected to experience substantial growth in the coming years. It is anticipated to expand to $15.11 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.1%. This expansion during the forecast period is driven by factors such as increased travel to endemic areas, broader adoption of multiplex diagnostic technologies, a surge in outdoor recreational pursuits, rising demand for home-based testing kits, and heightened apprehension regarding co-infections with other tick-borne illnesses. Significant trends expected in the forecast timeframe include progress in molecular diagnostic techniques, advancements in biomarker research, innovation in point-of-care testing devices, evolution in lab-on-a-chip (microfluidic) technology, and improvements in immunoassay technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25817&type=smp

What Are The Drivers Pushing New Developments In The Lyme Disease Testing Market?

The escalating occurrence of tick-borne illnesses is anticipated to fuel the expansion of the lyme disease testing market. These illnesses encompass a range of diseases transmitted to humans via bites from infected ticks, which are small, blood-feeding parasites prevalent in grassy, wooded, or rural environments. The growing need for tick-borne illness treatments is largely propelled by climate change, which has broadened the geographic spread of ticks, consequently raising human exposure and infection rates. Since tick-borne illnesses are the primary means of contracting Lyme disease, there is a vital need for early detection and diagnosis to effectively manage the increasing number of infection cases, thereby boosting demand for testing. For instance, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 71,346 cases of tick-borne disease were reported in 2022 as of July 2024, marking an increase from 36,177 cases in 2021. Consequently, the rising prevalence of tick-borne illnesses is a significant driver for the growth of the lyme disease testing market.

What Are The Different Segment Classifications Within The Lyme Disease Testing Market?

The lyme disease testing market covered in this report is segmented –

1) By Test Type: Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types

2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies

3) By Disease Stage: Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection

4) By Sample Type: Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples

5) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations

Subsegments:

1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)

2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)

3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests

4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools

What Trends Are Expected To Drive The Lyme Disease Testing Market?

Leading companies in the Lyme disease testing market are prioritizing technological innovations in diagnostic instruments to improve test accuracy, shorten turnaround times, and facilitate early detection of the condition. These diagnostic instruments include medical devices, kits, or technologies utilized to identify Lyme disease by detecting specific antibodies, antigens, or genetic material related to the Borrelia burgdorferi bacteria. For example, in August 2024, EpitogenX Ltd., a UK-based biotechnology firm, revealed the introduction of an advanced Lyme Disease Diagnostic Kit. This kit is an ELISA-based assay created using their proprietary EpitoGen platform, featuring approximately 120 distinct Borrelia epitopes, which provides high specificity and sensitivity, and is designed for research use only (RUO). It supports early, strain-specific detection and can be customized for various laboratory applications. Tailored for research and diagnostic labs, it is optimal for enhancing detection precision and fostering more comprehensive insights into Lyme disease.

Which Key Players Are Driving Competition In The Lyme Disease Testing Market?

Major companies operating in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMÉRIEUX, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Everlywell, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Novatein Biosciences, Lyme Diagnostics Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/lyme-disease-testing-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Lyme Disease Testing Market?

North America was the largest region in the lyme disease testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Lyme Disease Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25817&type=smp

Browse Through More Reports Similar to the Global Lyme Disease Testing Market 2025, By The Business Research Company

Infectious Disease Diagnostics Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Biologics Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Covid 19 Saliva Screening Test Potential Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795